CD8A and neoplasm: We conducted in vivo CD8+ T cell depletion in mice using CD8α monoclonal antibody (10 mg kg−1; BE0004-1; Bio X Cell) to further validate the role of CD8+ T cells in tumor rejection observed in Fig. 7f.